P LibbyInflammation in atherosclerosisNature420868874200210.1038/nature0132312490960

GK HanssonA HermanssonThe immune system in atherosclerosisNat Immunol12204212201110.1038/ni.200121321594

E WestphalM HerzbergI NeumannL BeibeiC PilowskiC LiK WerdanH LoppnowNeutrophils process interleukin-1beta and interleukin-18 precursors in a caspase-1-like fashion - processing is inhibited by human vascular smooth muscle cellsEur Cytokine Netw171928200616613759

H LoppnowK WerdanW BuerkeVascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanismsInnate Immun146387200810.1177/175342590809124618713724

C GabayC LamacchiaG PalmerIL-1 pathways in inflammation and human diseasesNat Rev6232241201020177398

M SahooI Ceballos-OlveraL del BarrioF ReRole of the inflammasome, IL-1β, and IL-18 in bacterial infectionsScientificWorldJournal11203720502011

MG NeteaA SimonF van de VeerdonkBJ KullbergJW van der MeerLA JoostenIL-1beta processing in host defense: beyond the inflammasomesPLoS Pathog6e1000661201010.1371/journal.ppat.100066120195505

JA GracieSE RobertsonIB McInnesInterleukin-18J Leukoc Biol73213224200310.1189/jlb.0602313

K SchroderJ TschoppThe inflammasomesCell140821832201010.1016/j.cell.2010.01.04020303873

F BauernfeindA AblasserE BartokS KimJ Schmid-BurgkT CavlarV HornungInflammasomes: current understanding and open questionsCell Mol Life Sci68765783201110.1007/s00018-010-0567-421072676

F MartinonV PétrilliA MayorA TardivelJ TschoppGout-associated uric acid crystals activate the NALP3 inflammasomeNature440237241200610.1038/nature0451616407889

V PétrilliS PapinC DostertA MayorF MartinonJ TschoppActivation of the NALP3 inflammasome is triggered by low intracellular potassium concentrationCell Death Diff1415831589200717599094

F MartinonL AgostiniE MeylanJ TschoppIdentification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasomeCurr Biol1419291934200410.1016/j.cub.2004.10.02715530394

L AgostiniF MartinonK BurnsMF McDermottPN HawkinsJ TschoppNALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorderImmunity203193252004

M RazmaraSM SrinivasulaL WangJL PoyetBJ GeddesPS DiStefanoJ BertinES AlnemriCARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosisJ Biol Chem2771395213958200210.1074/jbc.M10781120011821383

H ZhangW FuNDPP1 is a novel CARD domain containing protein which can inhibit apoptosis and suppress NF-kappaB activationInt J Oncol2010351040200211956601

A FontalbaV Martinez-TaboadaO GutierrezC PipaonN BenitoA BalsaR BlancoJL Fernandez-LunaDeficiency of the NF-kappaB inhibitor caspase activating and recruitment domain 8 in patients with rheumatoid arthritis is associated with disease severityJ Immunol17948674873200710.4049/jimmunol.179.7.486717878386

DPB McGovernH ButlerT AhmadM PaolucciDA van HeelK NegoroP HysiJ RagoussisSPL TravisLR CardonDP JewellTUCAN (CARD8) genetic variants and inflammatory bowel diseaseGastroenterology13111901196200610.1053/j.gastro.2006.08.00817030188

RD BagnallRG RobertsMM MirzaT TorigoeNJ PrescottCG MathewNovel isoforms of the CARD8 (TUCAN) gene evade a nonsense mutationEur J Hum Genet16619625200810.1038/sj.ejhg.520199618212821

M YamamotoT TorigoeK KamiguchiY HirohashiK NakanishiC NabetaH AsanumaT TsuramaT SatoF HataA novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosisCancer Res6587068714200510.1158/0008-5472.CAN-04-464916204039

D WågsäterK JattaP OcayaJ DimbergA SirsjöExpression of IL-1beta, IL-1 receptor type I and IL-1 receptor antagonist in human aortic smooth muscle cells: effects of all-trans-retinoic acidJ Vasc Res43377382200616804330

PS OlofssonY SheikineK JattaM GhaderiA SamnegårdP ErikssonA SirsjöA functional interleukin-1 receptor antagonist polymorphism influences atherosclerosis development. The interleukin-1beta:interleukin-1 receptor antagonist balance in atherosclerosisCirc J7315311536200910.1253/circj.CJ-08-1150

J GaleaJ ArmstrongP GadsdonH HoldenSE FrancisCM HoltInterleukin-1 beta in coronary arteries of patients with ischemic heart diseaseAtheroscler Thromb Vasc Biol1610001006199610.1161/01.ATV.16.8.10008696938

WP ArendG PalmerC GabayIL-1, IL-18, and IL-33 families of cytokinesImmunol Rev2232038200810.1111/j.1600-065X.2008.00624.x18613828

SF FisherMM MirzaCM OnnieD SoarsCM LewisNJ PrescottCG MathewJ SandersonA ForbesC TodhunterCombined evidence from three large british association studies rejects TUCAN/CARD8 as an IBD susceptibility geneGastroenterology13220782080200710.1053/j.gastro.2007.03.08617484911

P LibbyJM OrdovasKR AugerAH RobbinsLK BirinyiCA DinarelloEndotoxin and tumor necrosis factor induce inter-leukin-1 gene expression in adult human vascular endothelial cellsAm J Pathol12417918519863526909

P ZhuL DuanJ ChenA XiongQ XuH ZhangF ZhengZ TanF GongM FangGene silencing of NALP3 protects against liver ischemia-reperfusion injury in miceHum Gene Ther22853864201110.1089/hum.2010.14521128730

K YamasakiJ MutoKR TaylorAL CogenD AudishJ BertinEP GrantAJ CoyleA MisaghiHM HoffmanRL GalloNLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injuryJ Biol Chem2841276212771200910.1074/jbc.M80608420019258328

P KankkunenL TeirilaJ RintahakaH AleniusH WolffS Matikainen(1,3)-beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophagesJ Immunol18463356342201010.4049/jimmunol.090301920421639